SMN1 and proximal spinal muscular atrophy: Some recent research supports the proactive approach of early treatment of SMA to reduce symptoms and improve quality of life, especially for patients with four copies of SMN2 genes [28,37], despite a higher likelihood of SMA3 than SMA2 in patients with four copies of SMN2 genes [38].